Sherene Loi
0000-0001-6137-9171
Publication & Citation Trends
Publications
0 total
Whole-genome sequencing in breast cancer: is it ready for clinical application?
Cited by 0
Semantic Scholar
Microtubule targeting agents influence the clinical benefit of immune response in early breast cancer. OA
Cited by 0
Semantic Scholar
Towards targeting the breast cancer immune microenvironment
Cited by 256
Semantic Scholar
Annotation-efficient deep learning for breast cancer whole-slide image classification using tumour infiltrating lymphocytes and slide-level labels OA
Cited by 9
Semantic Scholar
Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset.
Cited by 6
Semantic Scholar
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial. OA
Cited by 1,194
Semantic Scholar
Pertuzumab: new hope for patients with HER2-positive breast cancer. OA
Cited by 161
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(453)
Advanced Breast Cancer Therapies
(354)
HER2/EGFR in Cancer Research
(244)
Breast Cancer Treatment Studies
(242)
Cancer Genomics and Diagnostics
(208)
Affiliations
Université Paris-Sud
St. Andrews University
Champalimaud Foundation
Ulsan College
Roche (Switzerland)